{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:34:36Z","timestamp":1793208876270,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Influenza-like illness (ILI) is a clinical syndrome caused by multiple respiratory pathogens and does not necessarily represent laboratory-confirmed influenza. Children receiving cancer therapy may experience substantial morbidity and treatment interruption from ILI, but data from low- and middle-income countries remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To estimate the incidence of ILI, describe its clinical characteristics, management, treatment impact, and outcomes, and identify independent predictors of inpatient management and inpatient duration in children receiving cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed children aged 14 years or younger who received cancer-directed therapy at a tertiary cancer center in Kerala, India, from January through December 2022. ILI was defined using World Health Organization criteria. Patient time was calculated from the exact time receiving active therapy and under observation. Episode-level logistic and Poisson generalized estimating-equation models accounted for repeated episodes within children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Seventy-nine of 110 children (71.8%) developed 209 ILI episodes over 68.95 patient-years, corresponding to 3.03 episodes per patient-year (95% CI: 2.63-3.47). The median age of affected children was 4 years (IQR=2 to 6), and 62 (78.5%) had hematological malignancies. Seventy-four episodes (35.4%) were managed as inpatients, including 30 hospital-onset episodes; 44 of 179 community-onset episodes (24.6%) resulted in admission. Lower respiratory tract infection occurred in 33 episodes (15.8%). Severe pneumonia occurred during 9 episodes involving 7 children; all required intensive care. Two children developed multiple organ dysfunction syndrome, required ventilation, and died, corresponding to an ILI-related mortality of 2.5% among affected children. Chemotherapy was delayed in 64 episodes (30.6%); among 62 episodes with assessable duration, the median delay was 7 days (IQR=4 to 7). Viral testing was performed in 26 episodes (12.4%); SARS-CoV-2 was detected in 9 of 24 rapid antigen tests (37.5%). Younger age independently predicted inpatient management (adjusted odds ratio=0.78 per year; 95% CI: 0.65-0.93;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.006). Female sex (adjusted incidence rate ratio=0.77; 95% CI: 0.63-0.94;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.012) and solid-tumor diagnosis (adjusted incidence rate ratio=0.71; 95% CI: 0.57-0.89;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.003) were associated with shorter inpatient duration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Syndromic ILI was frequent and was associated with inpatient care, severe complications, and chemotherapy interruption. Younger children had higher odds of inpatient management. Limited pathogen testing restricts etiological interpretation and supports improved access to respiratory diagnostics, risk-adapted antimicrobial stewardship, and age- and treatment-appropriate vaccination against preventable respiratory infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003277","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:00:09Z","timestamp":1789581609000},"page":"378-384","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Influenza-Like Illness in Children With Cancer: Incidence, Predictors, and Outcomes From a Tertiary Cancer Center in India"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-0173","authenticated-orcid":false,"given":"Jithin","family":"T. K.","sequence":"first","affiliation":[{"name":"Division of Pediatric Oncology, Malabar Cancer Centre - Postgraduate Institute of Oncology Sciences and Research, Thalassery, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-379X","authenticated-orcid":false,"given":"Kaduveetil G.","family":"Gopakumar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, Malabar Cancer Centre - Postgraduate Institute of Oncology Sciences and Research, Thalassery, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarath","family":"K. E.","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Malabar Cancer Centre -Postgraduate Institute of Oncology Sciences and Research, Thalassery, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2471\/BLT.17.194514","article-title":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection","volume":"96","author":"Fitzner","year":"2018","journal-title":"Bull World Health Organ"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jmv.25432","article-title":"Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients","volume":"91","author":"Soudani","year":"2019","journal-title":"J Med Virol"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08880018.2019.1631920","article-title":"Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia","volume":"36","author":"Meena","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0000000000001209","article-title":"Respiratory viral infections and coinfections in children with cancer, fever and neutropenia: clinical outcome of infections caused by different respiratory viruses","volume":"35","author":"Torres","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"100119","DOI":"10.1016\/j.ejcped.2023.100119","article-title":"Respiratory viral infections in pediatric hematology\/oncology patients","volume":"2","author":"Santolaya","year":"2023","journal-title":"EJC Paediatr Oncol"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/INF.0b013e31825c4b7e","article-title":"Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia","volume":"31","author":"Torres","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmi.2016.11.001","article-title":"Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial","volume":"23","author":"Santolaya","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08880018.2016.1276235","article-title":"Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia","volume":"34","author":"Yeoh","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0041-1729513","article-title":"Chemotherapy delays are associated with inferior outcomes in acute lymphoblastic leukemia: a retrospective study from a tertiary cancer center in South India","volume":"42","author":"Agrawal","year":"2021","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14737159.2024.2353690","article-title":"Sample-to-result molecular diagnostic platforms and their suitability for infectious disease testing in low- and middle-income countries","volume":"24","author":"Hauner","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.24953\/turkjped.2018.06.005","article-title":"Respiratory viral infection\u2019s frequency and clinical outcome in symptomatic children with cancer: a single-center experience from a middle-income country","volume":"60","author":"B\u00fcy\u00fckkapu-Bay","year":"2018","journal-title":"Turk J Pediatr"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1055\/s-0044-1791970","article-title":"Frequency and clinical outcomes of respiratory infections in children with cancer presenting with febrile illness","volume":"14","author":"Srinivasan","year":"2025","journal-title":"South Asian J Cancer"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12879-019-3920-8","article-title":"Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial","volume":"19","author":"El Guerche-S\u00e9blain","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3201\/eid1503.080238","article-title":"Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007","volume":"15","author":"Gordon","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11899-016-0337-y","article-title":"Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances","volume":"11","author":"Vrooman","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"e0124122","DOI":"10.1371\/journal.pone.0124122","article-title":"Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing","volume":"10","author":"Chadha","year":"2015","journal-title":"PLoS One"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2019.08.008","article-title":"Treatment-related mortality in children with cancer: prevalence and risk factors","volume":"121","author":"Loeffen","year":"2019","journal-title":"Eur J Cancer"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"707691","DOI":"10.1155\/2014\/707691","article-title":"Guidelines on vaccinations in pediatric hematology and oncology patients","volume":"2014","author":"Cesaro","year":"2014","journal-title":"Biomed Res Int"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s13312-019-1678-0","article-title":"Immunization of children with cancer in India treated with chemotherapy\u2014consensus guideline from the Pediatric Hematology-Oncology Chapter and the Advisory Committee on Vaccination and Immunization Practices of the Indian Academy of Pediatrics","volume":"56","author":"Moulik","year":"2019","journal-title":"Indian Pediatr"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:00:23Z","timestamp":1793206823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003277","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"2025-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}